Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
300 participants
INTERVENTIONAL
2020-02-01
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
NCT01444235
Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting
NCT05514652
Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients
NCT05354648
Intertransverse Process Block for Postoperative Acute Pain After Coronary Bypass Surgery
NCT06908681
Comparison of stAndard and Hybrid Surgical Techniques in the Treatment of proximaL Aortic dissEctions
NCT03711136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thoracic epidural analgesia
CABG and thoracic epidural analgesia will be used for perioperative analgesia postoperative period
CABG
coronary artery bypass grafting with and without cardiopulmonary bypass
thoracic epidural analgesia
thoracic epidural analgesia at the level of 1-10 thoracic vertebrae (ropivacainum 0,2-0,5% 5-10 ml/h)
Opioids
CABG and opioids will be used for perioperative analgesia
CABG
coronary artery bypass grafting with and without cardiopulmonary bypass
analgesia of opioids
Opioids will be used for perioperative analgesia
CABG
coronary artery bypass grafting with and without cardiopulmonary bypass
CABG
coronary artery bypass grafting with and without cardiopulmonary bypass
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CABG
coronary artery bypass grafting with and without cardiopulmonary bypass
thoracic epidural analgesia
thoracic epidural analgesia at the level of 1-10 thoracic vertebrae (ropivacainum 0,2-0,5% 5-10 ml/h)
analgesia of opioids
Opioids will be used for perioperative analgesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Volgograd State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mikhail I Turovets, MD
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital №1 of Volgograd State Medical University
Volgograd, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEA-CABG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.